MAPK3 and endometrial cancer: Since AKT and ERK1/2 play important roles in IGF1R signaling, the apoptotic and anti-proliferative action of methyl jasmonate in endometrial cancer cells can be enhanced by co-targeting the insulin-like growth factor-1 receptor (IGF1R) signaling pathway.